Cargando…

Safety and Efficacy of PTH 1‐34 and 1‐84 Therapy in Chronic Hypoparathyroidism: A Meta‐Analysis of Prospective Trials

Hypoparathyroidism is the only endocrine deficiency for which hormone replacement therapy is not the standard of care. Although conventional treatments may control hypocalcaemia, other complications such as hyperphosphatemia, kidney stones, peripheral calcifications, and bone disease remain unmet ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puliani, Giulia, Hasenmajer, Valeria, Simonelli, Ilaria, Sada, Valentina, Pofi, Riccardo, Minnetti, Marianna, Cozzolino, Alessia, Napoli, Nicola, Pasqualetti, Patrizio, Gianfrilli, Daniele, Isidori, Andrea M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545848/ https://www.ncbi.nlm.nih.gov/pubmed/35485213 http://dx.doi.org/10.1002/jbmr.4566

Ejemplares similares

Pituitary adenoma consistency affects postoperative hormone function: a retrospective study
por: De Alcubierre, Dario, et al.
Publicado: (2023)

Use of rhPTH(1-84) for hypoparathyroidism during early pregnancy and lactation
por: Liao, E Pauline, et al.
Publicado: (2023)

Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism
por: Fuss, Carmina Teresa, et al.
Publicado: (2020)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1–84) treatment
por: Marcucci, G., et al.
Publicado: (2022)

Non-Canonical Effects of ACTH: Insights Into Adrenal Insufficiency
por: Hasenmajer, Valeria, et al.
Publicado: (2021)

Selenium Supplementation in Pregnant Women with Autoimmune Thyroiditis: A Practical Approach
por: Minnetti, Marianna, et al.
Publicado: (2022)

Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1–84)
por: Chen, Kristina S, et al.
Publicado: (2020)

OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism
por: Ahmed, Intekhab, et al.
Publicado: (2022)

Effects of parathyroid hormone rhPTH(1–84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study
por: Clarke, Bart L., et al.
Publicado: (2016)

Serum Calcium Levels in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Rejnmark, Lars, et al.
Publicado: (2021)

Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1–84): A Retrospective Cohort Study
por: Ayodele, Olulade, et al.
Publicado: (2022)

Subcutaneous Infusion of rhPTH(1-34) During Pregnancy and Nursing in a Woman With Autosomal Dominant Hypoparathyroidism 1
por: Shulman, Dorothy
Publicado: (2022)

Desperate Times Call for Desperate Measures: Use of Continuous Subcutaneous 1-34 PTH Infusion for Postsurgical Hypoparathyroidism
por: Haider, Adnan, et al.
Publicado: (2021)

Risk of Chronic Kidney Disease in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Gosmanova, Elvira, et al.
Publicado: (2021)

Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study
por: Ayodele, Olulade, et al.
Publicado: (2022)

Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool
por: Minnetti, Marianna, et al.
Publicado: (2022)

Short-Term PTH(1-34) Therapy in Children to Correct Severe Hypocalcemia and Hyperphosphatemia due to Hypoparathyroidism: Two Case Studies
por: Mishra, Pooja E., et al.
Publicado: (2016)

ODP118 PTH (1-34) Replacement Therapy for Hypoparathyroidism due to Sporadic Calcium Sensing Receptor Gain-of-Function Point Mutation
por: Basina, Marina, et al.
Publicado: (2022)

Low health-related quality of life in hypoparathyroidism and need for PTH analog
por: Kontogeorgos, Georgios, et al.
Publicado: (2021)

Comparing the values of intact parathormone and 1– 84 PTH to predict hyperparathyroidism in hemodialysis patients
por: Jenabi, Aria, et al.
Publicado: (2017)

In Vitro Effects of PTH (1-84) on Human Skeletal Muscle-Derived Satellite Cells
por: Romagnoli, Cecilia, et al.
Publicado: (2023)

Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
por: Isidori, Andrea M, et al.
Publicado: (2020)

COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders
por: Cozzolino, Alessia, et al.
Publicado: (2023)

Altered Thyroid Feedback Loop in Klinefelter Syndrome: From Infancy Through the Transition to Adulthood
por: Carlomagno, Francesco, et al.
Publicado: (2023)

Testicular Dysfunction in 47,XXY Boys: When It All Begins. A Semilongitudinal Study
por: Pozza, Carlotta, et al.
Publicado: (2023)

1,25-Dihydroxyvitamin D to PTH(1–84) Ratios Strongly Predict Cardiovascular Death in Heart Failure
por: Gruson, Damien, et al.
Publicado: (2015)

Testicular ultrasound score: A new proposal for a scoring system to predict testicular function
por: Pozza, Carlotta, et al.
Publicado: (2020)

SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues
por: Ramezani-Pour, Narjes, et al.
Publicado: (2020)

Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism
por: Watts, Nelson B, et al.
Publicado: (2023)

Endogenous PTH Deficiency Impairs Fracture Healing and Impedes the Fracture-Healing Efficacy of Exogenous PTH(1-34)
por: Ren, Yongxin, et al.
Publicado: (2011)

PSAT158 Dimeric [Cys25]PTH(1-34) and Monomeric PTH(1-34) Differentially Regulate the Expression of Genes Related to Calcium Homeostasis in Bone and Kidney
por: Lee, Sihoon, et al.
Publicado: (2022)

Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?
por: Graziadio, Chiara, et al.
Publicado: (2018)

Continuous infusion of PTH(1–34) delayed fracture healing in mice
por: Yukata, Kiminori, et al.
Publicado: (2018)

PTH [1–34] induced differentiation and mineralization of mandibular condylar cartilage
por: O’ Brien, Mara Heather, et al.
Publicado: (2017)

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study
por: Feola, T., et al.
Publicado: (2022)

Interactome of PTH-Regulated miRNAs and Their Predicted Target Genes for Investigating the Epigenetic Effects of PTH (1–34) in Bone Metabolism
por: Vrščaj, Lucija Ana, et al.
Publicado: (2022)

Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
por: Pietrogrande, Luca
Publicado: (2010)

Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors
por: Campolo, Federica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ac9gusoi6j7qa00k6fricfqrpo